(Hypertension. 2002;39:433.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Department of Cardiology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Correspondence to Kenichi Yasunari, MD, Department of Cardiology, Graduate School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan. E-mail yasunari{at}osaka.med.or.jp
Angiotensin IImediated oxidative stress may play a role in the pathogenesis of coronary atherosclerosis. We examined the effects of pressure on the angiotensin IImediated increase in oxidative stress and migration of cultured human coronary smooth muscle cells (SMCs). Increased pressure (100 mm Hg) by helium gas for 48 hours increased angiotensin IImediated oxidative stress as evaluated by flow cytometry and SMC migration (from 15.9±2.2 to 32.0±2.4 cells per 4 high-power fields, P<0.05; n=8). The pressure-induced increases in oxidative stress observed appear to involve phospholipase D (PLD) and protein kinase C (PKC), inasmuch as the indirect PLD inhibitor suramin, at 100 µmol/L, and the PKC inhibitor chelerythrine, at 1 µmol/L, completely blocked the increase in angiotensin IImediated oxidative stress induced by pressure. Pressure-induced increase in angiotensin IImediated oxidative stress was inhibited by diphenylene iodonium chloride, an NADPH oxidase inhibitor, by 79% (P<0.05, n=8). Losartan (1 µmol/L), its active metabolite E3174 (1 µmol/L), and the antioxidant N-acetylcysteine (100 mmol/L) but not PD123319 (1 µmol/L) also blocked pressure-induced increases in angiotensin IImediated oxidative stress and SMC migration (P<0.05, n=8). These findings suggest a novel cellular mechanism whereby pressure regulates the angiotensin IImediated migration of SMCs, possibly via angiotensin II type 1 receptors, and which involves PLD-mediated, PKC-mediated, and NADPH oxidasemediated increases in oxidative stress.
Key Words: oxidative stress coronary disease atherosclerosis
This article has been cited by other articles:
![]() |
M. Labios, M. Martinez, F. Gabriel, V. Guiral, F. Dasi, B. Beltran, and A. Munoz Superoxide dismutase and catalase anti-oxidant activity in leucocyte lysates from hypertensive patients: effects of eprosartan treatment Journal of Renin-Angiotensin-Aldosterone System, March 1, 2009; 10(1): 24 - 30. [Abstract] [PDF] |
||||
![]() |
Q. Zeng, Q. Zhou, F. Yao, S. T. O'Rourke, and C. Sun Endothelin-1 Regulates Cardiac L-Type Calcium Channels via NAD(P)H Oxidase-Derived Superoxide J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 732 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Brandes and J. Kreuzer Vascular NADPH oxidases: molecular mechanisms of activation Cardiovasc Res, January 1, 2005; 65(1): 16 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morita, K. Iizuka, K. Okita, T. Oikawa, K. Yonezawa, T. Nagai, Y. Tokumitsu, T. Murakami, A. Kitabatake, and H. Kawaguchi Exposure to pressure stimulus enhances succinate dehydrogenase activity in L6 myoblasts Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1064 - E1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lassegue and R. E. Clempus Vascular NAD(P)H oxidases: specific features, expression, and regulation Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R277 - R297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Li and A. M. Shah ROS Generation by Nonphagocytic NADPH Oxidase: Potential Relevance in Diabetic Nephropathy J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S221 - 226. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |